Login
Vaccine Victims Left Disabled After Taking COVID Jab React to Bombshell Yale Study That Found Shots Cause Extreme Body Changes
When a new Yale University study identified a debilitating syndrome linked to COVID-19 vaccines, Lindy Ayers breathed a sigh of relief. The 31-year-old Army veteran, from Arkansas, has been wheelchair-bound since she took her second Pfizer shot in 2021 as part of the government’s military mandate.
For years she was told her extreme fatigue, sickness and heart palpitations were anxiety. Then doctors said it was long COVID. She was branded an antivaxxer for suggesting it could have been the vaccine.
Thousands of Americans have reported similar stories. After the study news dropped, DailyMail.com spoke to dozens of Americans, including those in healthcare, law, and the military, who said they felt a sense of validation after years of being dismissed as crazy.
RFK Jr. Prepares Shake-up of Vaccine Advisers
The U.S. Department of Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. is preparing to remove members of the outside committees that advise the federal government on vaccine approvals and other key public health decisions, according to two people familiar with the planning. Kennedy plans to replace members who he perceives to have conflicts of interest, as part of a widespread effort to minimize what he’s criticized as undue industry influence over the nation’s health agencies, said one of the people, who were granted anonymity to speak freely.
Kennedy has long argued that drugmakers have too much sway over the approval of their products. The effort is likely to target the Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices, which plays a key role in setting vaccine policy. Kennedy and his top aides are also scrutinizing a host of other outside panels, including those that advise the U.S. Food and Drug Administration.
Kennedy has only just begun evaluating the advisory committees, one of the people cautioned, and has not decided who or how many people will be replaced, or set a firm timeline for the removals.
Nationwide Drug Recall: Injectables Mislabeled, May Result in Overdose and Death
Bags of IV drugs distributed nationwide are being recalled for being mislabeled as a lesser-dose than what the drugs actually are, increasing the risk for overdosing and even death, according to the U.S. Food and Drug Administration.
ICU Medical Inc. is recalling one lot of potassium chloride injectables 20mEq, as the bags were over-wrapped with labels that state the drug is only 10 mEq. The 20 mEq was correctly printed on the IV bags, however, the 10 mEq over-wrap label makes it not easily visible to users, the company said in a statement.
Potassium chloride is used to treat hypokalemia — a condition where people have lower-than-normal blood potassium levels. It can be caused by “excessive loss of potassium” through vomiting, diarrhea, laxative use or some generic conditions.
A ‘Twin Epidemic’: Co-Prescribed Stimulants and Opioids Linked to Higher Opioid Doses
The combination of prescribed central nervous system stimulants, such as drugs that relieve ADHD symptoms, with prescribed opioid medications is associated with a pattern of escalating opioid intake, a new study has found.
The analysis of health insurance claims data from almost three million U.S. patients investigated prescribed stimulants’ impact on prescription opioid use over 10 years, looking for origins of the so-called “twin epidemic” of combining the two classes of drugs, which can increase the risk for overdose deaths.
“Combining the two drugs is associated with an increase in overdose deaths. This is something we know. But we didn’t know whether stimulant use has a causal role in the high use of opioids, so we conducted a big data analysis of how these two patterns interacted over a long period of time,” said senior study author Ping Zhang, associate professor of computer science and engineering and biomedical informatics at The Ohio State University.
Semaglutide Tied to Small Risk of Potentially Blinding Eye Condition
The use of semaglutide (Ozempic) was tied to a small risk of nonarteritic anterior ischemic optic neuropathy (NAION) in adults with Type 2 diabetes, according to a retrospective study.
In this review of 37.1 million patients, the incidence rate of NAION among semaglutide users was 14.5 and 8.7 per 100,000 person-years using the sensitive and specific NAION definitions, respectively, reported Cindy X. Cai, MD, MS, of Wilmer Eye Institute at Johns Hopkins School of Medicine in Baltimore, and colleagues in JAMA Ophthalmology.
The risk for NAION, which can cause sudden vision loss, using the sensitive definition — which required one ischemic optic neuropathy diagnosis code — was not different among new semaglutide users compared with users of the GLP-1 receptor agonist dulaglutide (Trulicity), the SGLT2 inhibitor empagliflozin (Jardiance), the DPP-4 inhibitor sitagliptin (Januvia), and the sulfonylurea glipizide.
Scientists Warn of Increased Mpox Transmission
International researchers, including from DTU National Food Institute, warn that the ongoing mpox outbreak in the Democratic Republic of the Congo (DRC) has the potential to spread across borders more rapidly. The mpox virus has mutated, and the new variant, clade 1b, has become more infectious.
Genetic analyses of clade 1b, first detected in September 2023 in Kamituga, DRC, show that this variant has since undergone mutations making it more easily transmissible between humans.
Scientists have identified three new subvariants, one of which has spread beyond Kamituga to other cities in the DRC, neighboring countries, and even internationally to e.g. Sweden and Thailand. The new data may also suggest that clade 1b entails a high risk of miscarriage.
Texas Measles Outbreak Nears 100 Cases, Raising Concerns About Undetected Spread
Some private schools have shut down because of a rapidly escalating measles outbreak in West Texas. Local health departments are overstretched, pausing other important work as they race to limit the spread of this highly contagious virus.
Since the outbreak emerged three weeks ago, the Texas health department has confirmed 90 cases with 16 hospitalizations, as of Feb. 21. Most of those infected are under age 18. Officials suspect that nine additional measles cases reported in New Mexico, across the border from the epicenter of the Texas outbreak in Gaines, are linked to the Texas outbreak.
Ongoing investigations seek to confirm that connection. Health officials worry they’re missing cases. Undetected infections bode poorly for communities because doctors and health officials can’t contain transmission if they can’t identify who is infected.
Shortage of Popular Drugs Wegovy and Ozempic Is Over, FDA Says.
The U.S. Food and Drug Administration (FDA) on Friday said the shortage of Novo Nordisk’s weight-loss and diabetes drugs Wegovy and Ozempic is resolved, a move that could limit the availability of cheaper compounded versions of the wildly popular medications.
In a statement, the FDA said it confirmed Novo Nordisk’s “stated product availability and manufacturing capacity” of these prescription drugs meets or exceeds current and projected demand. The agency warned consumers and doctors might still experience “limited localized supply disruptions” as the products are shipped from drug factories to distributors to pharmacies.
The Danish drugmaker Novo Nordisk said it has invested $6.5 billion this year in the United States to bolster drug production facilities that are operating 24/7, shipping Wegovy and Ozempic to wholesalers.
New mRNA Vaccine Tested in Mice Has Potential to Help Fight Tuberculosis
A new vaccine that boosts immunity against tuberculosis (TB) has been shown to be effective in pioneering pre-clinical trials, as part of a successful collaboration between three leading Australian research institutions.
A study into the vaccine’s effectiveness, published in eBioMedicine, was led by experts from the Sydney Infectious Diseases Institute at University of Sydney, the Centenary Institute and the Monash Institute of Pharmaceutical Science (MIPS) at Monash University. Currently, the only approved vaccine for TB is the century-old Bacillus Calmette-Guerin (BCG) vaccine, which is widely used despite its effectiveness in adults being inconsistent.
The study found that the new mRNA vaccine was successful in triggering an immune defense response that helped to reduce TB numbers in infected mice. In addition, the researchers discovered that for mice that had received the BCG vaccine, a booster dose of the new mRNA vaccine significantly improved their long-term protection.
